FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Monday

 

Sydney MS researchers link risk genes to Vitamin D





















Genetic risk factors of multiple sclerosis have been linked to Vitamin D activation. 
Image Source: THEAGE

The further away you live from the equator the more likely you are to be diagnosed with MS.

It sounds simple. But since analysis of the genetic determiners of multiple sclerosis began in the '70s, sunlight's factoring in the disease has seemed irreconcilable with its highly complex genetic make-up.

New research from scientists based at The Westmead Institute in Sydney has drawn a link between the genetic and environmental circumstances of multiple sclerosis, which affects 2.1 million people worldwide, most of whom are diagnosed between 20 and 40 years of age.

The project led by immunologist Dr David Booth capitalises on data from a landmark 2013 study that profiled the DNA of 30,000 MS patients worldwide. The study found there are more than 100 genetic risk factors of MS, which is characterised by the scarring of tissue in the central nervous system.

"Previously, it was thought that t-cells orchestrated an attack on the myelin sheath around nerves, causing their destruction," Dr Booth said. "Because we have found out the gene risk types, we now know there are various immune cells involved in this process, and different sub-sets of cells causing MS in different people."

Dr Booth and his team worked backwards to find the cellular source of two of the 110 genes associated with MS, called EOMES and TBX21.

Using blood samples from 50 patients of Westmead Hospital, they were able to identify the immune cell CD56+ as largely responsible for expressing the two risk factor genes. In MS patients, CD56+ cells were found to be inactive or deficient compared with the general population.

"The study has shown that whether these risk factor genes are turned on or off in the CD56+ cell, it is related to Vitamin D activation," Dr Booth explained.

"It's the first time we have been able to link the genetic risk factors of MS to environmental factors (ie. the absorption of sunlight) and this provides the possibility of new therapeutic pathways."

Booth stated that the team is yet to see whether enhancing Vitamin D activation will begin to turn on the genes expressed by the CD56+ cells, and whether this will alter multiple sclerosis symptoms.

"Potentially this research could lead to finding an environmental trigger for the disease or therapies that slow or prevent relapse of MS that are safer or more effective than those currently available," Booth said.

Hereditary and stable, TBX21 and EOMES genes could also be used as markers of MS patients who will respond to drugs targeting the CD56+ cell.


Story Source: The above story is based on materials provided by SYDNEYMORNINGHERALD
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News